Senior Research Director, Analytical Chemistry - Synthetic Molecule Design and Development at Eli Lilly and Company

Indianapolis, Indiana, United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Biotechnology, HealthcareIndustries

Skills

Key technologies and capabilities for this role

Analytical ChemistryHPLCMass SpectrometryNMR SpectroscopyDrug Substance DevelopmentDrug Product DevelopmentRegulatory SubmissionsProcess Analytical TechnologyPharmaceutical AnalysisQuality ControlMethod DevelopmentStability Testing

Questions & Answers

Common questions about this position

What is the salary for this Senior Research Director position?

This information is not specified in the job description.

Is this role remote or does it require working from a specific location?

This information is not specified in the job description.

What key skills are required for the Senior Research Director, Analytical Chemistry role?

The role requires a strong foundation in analytical sciences, experience in synthetic process or formulated product development, expertise in analytical strategies for drug substance and product development, and skills in authoring regulatory submissions like IND/CTA and NDA/MAA.

What is the company culture like at Eli Lilly?

Eli Lilly unites caring with discovery to make life better for people around the world, fosters a hardworking, culturally diverse workforce with deep technical expertise, and puts people first while giving back to communities.

What makes a strong candidate for this position?

Strong candidates are experienced, innovative, and motivated scientists with a strong foundation in analytical sciences, experience in synthetic process or product development, high learning agility, and the ability to lead multidisciplinary teams and deliver regulatory strategies.

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI